{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:49:24Z","timestamp":1782362964320,"version":"3.54.5"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>The <jats:italic>P4HTM<\/jats:italic> gene encodes a transmembrane prolyl 4-hydroxylase, which is responsible for the degradation of hypoxia-inducible transcription factors (HIF) under normoxia. Clinically, biallelic <jats:italic>P4HTM<\/jats:italic> variants have been identified in patients with hypotonia, hypoventilation, intellectual disabilities, dysautonomia, epilepsy, and eye abnormalities (HIDEA syndrome). Seizure was one of the most prominent symptoms. However, the clinical features of patients with epilepsy associated with <jats:italic>P4HTM<\/jats:italic> variants remain unclear. In this report, we describe a one-month-old infant with HIDEA syndrome caused by compound heterozygous <jats:italic>P4HTM<\/jats:italic> variants (c.300dupG\/p.Gly103Argfs*22 and c.488C\u2009&amp;gt;\u2009T\/p.Ala163Val). The infant presented with clonic seizures of focal onset that responded well to valproate, but with profound intellectual disability and global developmental delay at the last follow-up at 3\u2009years old. A review of the existing literature indicates that seizures in this population typically begin early in infancy, manifest in multiple types, and are relatively well controlled. Epilepsy seemed unrelated to developmental outcomes or disease progression. Valproate, which has HIF-1\u03b1 inhibiting properties, may be a promising treatment avenue for this population.<\/jats:p>","DOI":"10.3389\/fneur.2024.1428076","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:10:26Z","timestamp":1731042626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics of patients with P4HTM variant-associated epilepsy and therapeutic exploration: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Yan-Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Xiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Guang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"30544","DOI":"10.1074\/jbc.M704988200","article-title":"An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor \u03b1","volume":"282","author":"Koivunen","year":"2007","journal-title":"J Biol Chem"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/gb-2009-10-11-r130","article-title":"BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources","volume":"10","author":"Wu","year":"2009","journal-title":"Genome Biol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/s41436-019-0503-4","article-title":"Biallelic loss-of-function P4HTM gene variants cause hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities (HIDEA syndrome)","volume":"21","author":"Rahikkala","year":"2019","journal-title":"Genet Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ejmg.2014.07.002","article-title":"Clinical characterization, genetic mapping and whole-genome sequence analysis of a novel autosomal recessive intellectual disability syndrome","volume":"57","author":"Kaasinen","year":"2014","journal-title":"Eur J Med Genet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1002\/ajmg.a.61885","article-title":"Further delineation of HIDEA syndrome","volume":"182","author":"Maddirevula","year":"2020","journal-title":"Am J Med Genet A"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41431-021-00932-8","article-title":"Biallelic P4HTM variants associated with HIDEA syndrome and mitochondrial respiratory chain complex I deficiency","volume":"29","author":"Hay","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00439-021-02268-1","article-title":"Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland","volume":"140","author":"J\u00e4rvel\u00e4","year":"2021","journal-title":"Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/cge.14203","article-title":"HIDEA syndrome is caused by biallelic, pathogenic, rare or founder P4HTM variants impacting the active site or the overall stability of the P4H-TM protein","volume":"102","author":"Kraatari-Tiri","year":"2022","journal-title":"Clin Genet"},{"key":"ref9","year":"2024"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/ppul.25966","article-title":"HIDEA syndrome: a rare cause of congenital hypoventilation in a premature infant","volume":"57","author":"Lim","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00424-024-02920-5","article-title":"Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice","volume":"476","author":"Ala-Nisula","year":"2024","journal-title":"Pfl\u00fcg Arch Eur J Physiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"C58","DOI":"10.1152\/ajpcell.00160.2017","article-title":"mTORC1 is required for expression of LRPPRC and cytochrome-c oxidase but not HIF-1\u03b1 in Leigh syndrome French Canadian type patient fibroblasts","volume":"317","author":"Mukaneza","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/13543776.2016.1146252","article-title":"Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)","volume":"26","author":"Ban","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3341\/kjo.2017.31.1.80","article-title":"Effects of histone deacetylase inhibitor (Valproic acid) on the expression of hypoxia-inducible Factor-1 alpha in human retinal M\u00fcller cells","volume":"31","author":"Kim","year":"2017","journal-title":"Korean J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4062\/biomolther.2012.20.3.280","article-title":"Suppression of HIF-1\u03b1 by Valproic acid sustains self-renewal of mouse embryonic stem cells under hypoxia in vitro","volume":"20","author":"Lee","year":"2012","journal-title":"Biomol Ther"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1428076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:10:29Z","timestamp":1731042629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1428076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":17,"alternative-id":["10.3389\/fneur.2024.1428076"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1428076","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"article-number":"1428076"}}